Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Voss

Showing results (251-260 of 419) with videos related to

Pageof 42
Sort By:
BMJ Oncology|January 31, 2025
Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trialMatthew Tucker, Yu-Wei Chen, Martin H Voss, et al.
Journal of Natural Products|July 1, 2021
Feature-Based Molecular Networking for the Targeted Identification of G<sub>q</sub>-Inhibiting FR900359 DerivativesWiebke Hanke, Julian Patt, Judith Alenfelder, et al.
The Journal of Biological Chemistry|September 24, 2025
SAG1.3-derived Frizzled-targeting small-molecule compoundsLukas Grätz, Ainoleena Turku, Pawel Kozielewicz, et al.
Scientific Reports|November 2, 2019
Author Correction: Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Scientific Reports|May 31, 2019
Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Clinical Genitourinary Cancer|May 1, 2019
Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment OutcomesYasser Ged, Ying-Bei Chen, Andrea Knezevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
PTEN Expression, Not Mutation Status in <i>TSC1, TSC2</i>, or <i>mTOR</i>, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 TrialMartin H Voss, David Chen, Albert Reising, et al.
World Journal of Urology|March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomyAndrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
The Oncologist|April 8, 2015
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experienceRichard M Bambury, David J Benjamin, Joshua L Chaim, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Pageof 42

Showing results (251-260 of 419) with videos related to

Sort By:
Pageof 42
BMJ Oncology|January 31, 2025
Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trialMatthew Tucker, Yu-Wei Chen, Martin H Voss, et al.
Journal of Natural Products|July 1, 2021
Feature-Based Molecular Networking for the Targeted Identification of G<sub>q</sub>-Inhibiting FR900359 DerivativesWiebke Hanke, Julian Patt, Judith Alenfelder, et al.
The Journal of Biological Chemistry|September 24, 2025
SAG1.3-derived Frizzled-targeting small-molecule compoundsLukas Grätz, Ainoleena Turku, Pawel Kozielewicz, et al.
Scientific Reports|November 2, 2019
Author Correction: Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Scientific Reports|May 31, 2019
Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Clinical Genitourinary Cancer|May 1, 2019
Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment OutcomesYasser Ged, Ying-Bei Chen, Andrea Knezevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
PTEN Expression, Not Mutation Status in <i>TSC1, TSC2</i>, or <i>mTOR</i>, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 TrialMartin H Voss, David Chen, Albert Reising, et al.
World Journal of Urology|March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomyAndrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
The Oncologist|April 8, 2015
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experienceRichard M Bambury, David J Benjamin, Joshua L Chaim, et al.
JAMA Ophthalmology|September 2, 2021
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated RetinopathyJasmine H Francis, James J Harding, Alison M Schram, et al.
Pageof 42